Preparation method of 5-fluorouracil-1-methanal
A technology of fluorouracil and formaldehyde, which is applied in the field of 5-fluorouracil drug intermediate synthesis, can solve the problems of large toxic and side effects, low lipid solubility, difficulty in oral absorption, etc., and achieves the effects of high reaction yield and easy purification.
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2013-06-05
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
(1) Technical field
[0001] The invention relates to a new method for synthesizing 5-fluorouracil drug intermediates. (2) Background technology
[0002] According to the report of the World Health Organization, there are 20 million cancer patients in the world's total population of 6 billion, the incidence rate is about 3.3‰, and the average annual death rate of cancer patients is 12%. Statistics from the Ministry of Health of my country also show that there are currently 4.5 million cancer patients in my country, with an increase of about 2 million people every year. The national incidence rate of tumor is about 1.64‰. About 1.3 million people die from cancer every year in my country, and the mortality rate is 23%, which is higher than the global average annual mortality rate of 12%. According to a recent public statistical report by China Cancer Network, in less than 20 years, the incidence of cancer in my country has increased by 69%, and the death rate has increased by ...
Examples
Embodiment 1
[0037] Take 1.302g of 5-fluorouracil in a 100mL three-necked flask, add 20mL of water and 5mL of 37% formaldehyde, react at 55°C, track and detect by TLC, the reaction is complete in 6 hours, distill off the water, add 30mL of acetone, and 0.174g of manganese dioxide is oxidized , TLC tracking, after 4 hours of reaction, filtered, and the filtrate was evaporated to dryness to obtain 1.29 g of 5-fluorouracil-1-carbaldehyde, with a yield of 81.6%.
[0038] Spectral data of 5-fluorouracil-1-carbaldehyde: 1 H NMR (500MHz, DMSO-d 6 ,TMS)δ11.20(s,1H,NH of5-FU),8.20(s,1H,-CHO),7.67(d,1H,FC=CH, 3 J FH =6.5Hz) 13 C NMR (125MHz, DMSO-d 6 , TMS) δ, 52.0, 49.5, 36.3; IR (KBr, cm -1 )ν:3116,1722,1652,1558,1450,1396,1378,1243,1181,679;ESI-MS m / z:157[M-1] - .
[0039] The NMR was completed on the AVANCE-500 NMR analyzer of Bruker, Switzerland, the mass spectrometry was completed on the DECAX-30000LCQ DecaXP Plus of Finnigan Mass Spectrometry Company of the United States, and the infra...
Embodiment 2
[0041] Take 1.307g of 5-fluorouracil in a 100mL three-necked flask, add 2mL of formic acid and 1.12g of zinc oxide, 30mL of toluene, react at 110°C, TLC tracking detection, 20h complete reaction, cool to room temperature, filter to obtain solid and filtrate, and evaporate the filtrate to dryness , to obtain part of 5-fluorouracil-1-formaldehyde; the filtered solid was dissolved in 20mL of DMF, filtered, and the filtrate was evaporated to dryness to obtain 5-fluorouracil-1-formaldehyde, the total of the two was 0.95g, and the yield was 60.3%.
Embodiment 3
[0043]Take 1.303g of 5-fluorouracil in a 100mL three-necked flask, add 3mL of formic acid, 1.5g of silica gel powder, and 30mL of toluene, and react at 110°C. TLC tracking detection, the reaction is complete after 20 hours, cooled to room temperature, filtered to remove the silica gel, and evaporated to dryness. 0.26 g of solid 5-fluorouracil-1-carbaldehyde was obtained with a yield of 16.45%.
